Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3862995B in Bronchiectasis
NCT07201051Phase 2Recruiting
- Sponsor
- GSK
- Start
- Oct 2025
- Primary completion
- May 2027
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 2 trial of gsk3862995b in bronchiectasis, sponsored by GSK. Started Oct 2025; status: recruiting.
02
Drugs
gsk3862995b
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT07201051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07201051.